Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Masimo: Healthcare Data Analysis And Not Expensive
05:08am, Thursday, 23'rd Mar 2023
Masimo Corporation is a healthcare business that intends to improve the quality of life of its customers. I assumed that management will try to expand through new product categories, and will successf
Three Reasons to Add Masimo (MASI) Stock to Your Portfolio
01:46pm, Wednesday, 22'nd Mar 2023
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Masimo Corporation: Re-Rating Nearing Completion
06:41pm, Friday, 17'th Mar 2023
Masimo Corporation shares fell off a cliff early in 2022 amidst the pullback in momentum names and a poorly received deal for Sound. I like the long-term trajectory of the business and gave management
Masimo (MASI) Moves to Strong Buy: Rationale Behind the Upgrade
01:45pm, Friday, 17'th Mar 2023
Masimo (MASI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Masimo (MASI) PVi Achieves Acceptable Fluid Response in Study
09:10am, Thursday, 16'th Mar 2023
Masimo (MASI) PVi helps clinicians reliably predict fluid responsiveness in young neurosurgical patients.
Masimo (MASI) Q4 Earnings Surpass Estimates, Margins Down
09:47am, Wednesday, 01'st Mar 2023
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q4 sales.
Masimo (MASI) Q4 Earnings and Revenues Beat Estimates
09:50pm, Tuesday, 28'th Feb 2023
Masimo (MASI) delivered earnings and revenue surprises of 12.82% and 2.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo Corporation (MASI) Q4 2022 Earnings Call Transcript
09:22pm, Tuesday, 28'th Feb 2023
Masimo Corporation (NASDAQ:MASI ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Eli Kammerman - Vice President of Business Development & Investor Relations Joe Kia
Here's Why You Should Retain Masimo (MASI) Stock for Now
12:02pm, Monday, 20'th Feb 2023
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Apple Watch faces potential import ban over patent dispute with Masimo
03:20pm, Sunday, 19'th Feb 2023
A judge for the U.S. ITC ruled in January that Apple violated one of Masimo's patents for using light sensors to gauge blood oxygen levels in smartwatches.
Masimo's (MASI) Patient Monitoring Devices Favored by New Study
04:30pm, Wednesday, 25'th Jan 2023 Zacks Investment Research
Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.
Masimo's (MASI) Patient Monitoring Devices Favored by New Study
12:47pm, Wednesday, 25'th Jan 2023
Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.
Masimo (MASI) Expands Partnership with Philips for W1 Watch
06:15pm, Friday, 20'th Jan 2023 Zacks Investment Research
Masimo (MASI) and Royal Philips to create an open ecosystem of medical information using Masimo W1 watch and the latter???s patient monitoring ecosystem to improve home-care.
Masimo (MASI) Expands Partnership with Philips for W1 Watch
02:18pm, Friday, 20'th Jan 2023
Masimo (MASI) and Royal Philips to create an open ecosystem of medical information using Masimo W1 watch and the latter???s patient monitoring ecosystem to improve home-care.
